|
Market Closed -
Other stock markets
|
After hours 08:00:00 pm | |||
| 632.90 USD | +2.06% |
|
628.02 | -0.77% |
| Market Cap | 64.39B 56.46B 52.04B 48.72B 91.36B 6,074B 93.26B 625B 242B 3,002B 242B 237B 10,410B | P/E 2026 * |
16.4x | P/E 2027 * | 13.2x |
|---|---|---|---|---|---|
| Enterprise Value | 56.48B 49.52B 45.65B 42.73B 80.13B 5,328B 81.8B 549B 212B 2,633B 212B 207B 9,130B | EV / Sales 2026 * |
3.56x | EV / Sales 2027 * | 3.06x |
| Free-Float |
72.33% | Yield 2026 * |
0.62% | Yield 2027 * | 0.7% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | +2.06% | ||
| 1 week | +3.76% | ||
| Current month | +2.95% | ||
| 1 month | -0.27% | ||
| 3 months | -16.36% | ||
| 6 months | -19.37% | ||
| Current year | -18.00% |
| 1 week | 594.9 |  | 638.76 |
| 1 month | 591.52 | | 640.82 |
| Current year | 591.52 | | 821.11 |
| 1 year | 518.9 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 30 | Sell | Director | -100 | 0.0001% | ||
| Mar. 31 | Sell | Director | 100 | 0.0001% | ||
| Mar. 01 | Sell | Director | 100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.06% | +3.76% | +21.48% | -19.31% | 64.39B | |
| +0.74% | +3.52% | +53.14% | +219.37% | 56.12B | |
| -3.10% | +34.30% | +34.30% | +34.30% | 40.54B | |
| -2.36% | -1.25% | -52.13% | -58.98% | 37.98B | |
| +6.97% | +9.89% | +70.21% | -23.28% | 31.89B | |
| +12.59% | +5.18% | +144.26% | -44.13% | 26.69B | |
| +5.78% | +15.81% | +60.64% | +80.73% | 22.73B | |
| -1.25% | -1.31% | -4.39% | +142.42% | 16.66B | |
| -0.81% | +5.91% | +67.70% | +124.13% | 16.6B | |
| +0.79% | +5.99% | +55.67% | +353.45% | 13.76B | |
| Average | +2.14% | +4.49% | +45.09% | +80.87% | 32.74B | |
| Weighted average by Cap. | +1.91% | +4.19% | +39.89% | +59.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.88B 13.92B 12.83B 12.02B 22.53B 1,498B 23B 154B 59.69B 740B 59.63B 58.33B 2,567B | 17.55B 15.39B 14.19B 13.28B 24.9B 1,656B 25.42B 171B 65.98B 818B 65.91B 64.47B 2,838B |
| Net income | 4.09B 3.58B 3.3B 3.09B 5.8B 386B 5.92B 39.71B 15.37B 191B 15.35B 15.02B 661B | 5.13B 4.5B 4.15B 3.88B 7.28B 484B 7.43B 49.87B 19.3B 239B 19.28B 18.85B 830B |
| Net Debt | -7.91B -6.94B -6.4B -5.99B -11.23B -746B -11.46B -76.87B -29.74B -369B -29.71B -29.06B -1,279B | -10.69B -9.37B -8.64B -8.08B -15.16B -1,008B -15.48B -104B -40.16B -498B -40.12B -39.25B -1,727B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | $632.90 | +2.06% | 1,213,634 |
| 26-06-25 | $620.14 | -0.53% | 696,862 |
| 26-06-24 | $623.43 | +0.87% | 839,934 |
| 26-06-23 | $618.03 | +0.90% | 1,279,871 |
| 26-06-22 | $612.50 | +0.42% | 1,604,297 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
